Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Nov;43(5):307-13.
doi: 10.1007/BF00320954.

New antigenic determinant (Sa) on human lymphocytes and phagocytes

New antigenic determinant (Sa) on human lymphocytes and phagocytes

W Pruzanski et al. Blut. 1981 Nov.

Abstract

Presence of antigenic determinants reacting with homogeneous IgM/kappa cold agglutinin (CA) of a new specificity, tentatively called Sa, was investigated by bithermic cytotoxicity assay and by immunofluorescence. CA Sa killed on average 38% allogeneic peripheral blood lymphocytes (PBL) and up to 74% of autologous PBL. There was preferential kill of B-PBL compared to T-PBL. Some preference toward B cells was also noted using tonsillary B and T lymphocytes. Cytotoxic activity of CA Sa against chronic lymphocytic leukemia cells of B-type was almost equal to that of potent anti-I CA and much stronger than anti-i CA. Presence of additional B-cytotoxic factor in the serum was excluded by the use of red blood cell eluate composed solely of homogeneous CA. Thymocytes and helper-type T cells from a patient with T cell chronic lymphocytic leukemia were very susceptible to the cytotoxic action of Sa. CA Sa killed 39% of monocytes, but there was almost no kill of polymorphonuclear leukocytes. Lymphocytotoxicity of CA Sa was abolished by sialyllactose and was not influenced by I-active glycoproteins. Comparison of CA Sa to CA of other specificities showed marked differences, supporting the view that Sa has new, previously unrecognized specificity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Immunol Immunopathol. 1980 Apr;15(4):631-41 - PubMed
    1. N Engl J Med. 1977 Sep 8;297(10):538-42 - PubMed
    1. Clin Immunol Immunopathol. 1975 Jul;4(2):277-85 - PubMed
    1. Clin Exp Immunol. 1978 Aug;33(2):276-82 - PubMed
    1. Cancer. 1978 Jul;42(1):140-8 - PubMed